Neurological
|
March 11, 2025

MERRF Syndrome Explained: Diagnosis and Treatment

Written By
Medically Reviewed by
Updated On
March 26, 2025

Living with a rare condition like MERRF syndrome can be overwhelming, not just for those diagnosed but also for their families and caregivers. The sudden muscle jerks, difficulty with coordination, and progressive weakness can make everyday tasks more challenging. 

This article will provide a clear and compassionate guide to MERRF syndrome, covering its causes, symptoms, diagnosis, and treatment options. Whether you’re a patient, a caregiver, or simply seeking to learn more, this resource aims to offer the information and support you need.

[signup]

What is MERRF Syndrome?

Myoclonic Epilepsy with Ragged Red Fibers (MERRF) syndrome is a rare mitochondrial disorder that primarily affects the nervous and muscular systems. It is marked by muscle weakness that gets worse over time (myopathy), seizures (myoclonic epilepsy), and trouble coordinating movements (ataxia).

These symptoms result from genetic mutations that impair the function of mitochondria, the energy-producing structures in cells.

History of MERRF Syndrome

MERRF syndrome was first described in the late 1970s when researchers identified a unique pattern of myoclonic epilepsy with muscle pathology. Advances in genetic research later confirmed its association with mitochondrial DNA (mtDNA) mutations. Over time, scientists have categorized MERRF as part of a broader group of mitochondrial disorders.

Classification among Mitochondrial Disorders

MERRF belongs to the category of mitochondrial encephalomyopathies. Disorders that primarily impact both the brain (encephalo-) and muscles (myopathy). It shares similarities with other mitochondrial diseases, such as MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) and Leigh syndrome. 

Genetic Basis

MERRF syndrome is caused by mutations in mitochondrial DNA, which is inherited differently from nuclear DNA. Since mitochondria are passed down from the mother, MERRF follows a maternal inheritance pattern.

Mitochondrial DNA and Inheritance Patterns

Unlike nuclear DNA, which is inherited from both parents, mitochondrial DNA (mtDNA) is solely passed down from the mother. This distinction means that MERRF syndrome can be transmitted by affected or carrier mothers to their children. 

But heteroplasmy, a condition in which normal and mutated mitochondria live in the same cell, can make the disease very different between family members.

Common Genetic Mutations Associated with MERRF

MERRF is most often linked to a mutation in the MT-TK gene, which makes tRNA^Lys (transfer RNA for lysine). This mutation disrupts mitochondrial protein synthesis, leading to energy production deficits. Other less common mutations in mitochondrial genes, such as MT-TL1 and MT-TH, have also been associated with MERRF syndrome.

Pathophysiology

MERRF syndrome affects cellular function by impairing mitochondrial energy production. This dysfunction has widespread effects on the muscles, brain, and other high-energy-demand organs.

Cellular Impact of Mitochondrial Dysfunction

Mitochondria generate ATP (adenosine triphosphate), the cell's primary energy currency. In MERRF, genetic mutations reduce ATP production, leading to cellular stress and damage. As a result, tissues that rely heavily on energy, such as muscles and neurons, become dysfunctional, causing the syndrome's hallmark symptoms.

How Genetic Mutations Lead to Symptoms

The loss of efficient mitochondrial function triggers a cascade of problems:

  • Myoclonic Epilepsy: Neuronal dysfunction causes uncontrolled muscle jerks and seizures.
  • Muscle Weakness and Ataxia: ATP deficiency impairs muscle contraction and coordination.
  • Ragged Red Fibers: Muscle biopsies reveal these abnormal fibers due to increased and dysfunctional mitochondria in affected cells.
  • Other Systemic Effects: Some individuals experience hearing loss, cardiomyopathy (heart muscle disease), and peripheral neuropathy due to widespread energy deficits.

Symptoms and Diagnosis

MERRF syndrome affects multiple systems in the body, but its most noticeable symptoms arise in the nervous and muscular systems. Symptoms often begin in childhood or adolescence but can vary in severity and onset.

Neurological Symptoms (e.g., Myoclonus, Epilepsy)

One of the hallmark features of MERRF is myoclonus, which refers to sudden, involuntary muscle jerks. These jerks can occur randomly or be triggered by movement or touch.

Other common neurological symptoms include:

  • Epilepsy (seizures): Many individuals with MERRF experience recurrent seizures, which can range from mild to severe.
  • Ataxia: difficulty with coordination and balance, making walking and daily activities challenging.
  • Cognitive decline: Some individuals may experience memory problems, difficulty concentrating, or learning disabilities.
  • Peripheral neuropathy: damage to nerves outside the brain and spinal cord, leading to tingling, numbness, or weakness in the limbs.

Muscle Weakness and Ragged Red Fibers

Mitochondrial dysfunction in MERRF leads to progressive muscle weakness (myopathy), which may affect mobility and overall strength. MERRF is defined by the presence of ragged red fibers, abnormal muscle cells that look red under a microscope because their mitochondria are clumped together too much when they don't have enough energy.

Other Systemic Symptoms

Beyond neurological and muscular symptoms, MERRF can affect various other parts of the body:

  • Hearing loss: Progressive sensorineural hearing loss is common.
  • Short stature: Many individuals with MERRF have delayed growth and remain shorter than average.
  • Cardiac issues: Some may develop heart rhythm abnormalities (arrhythmias) or structural heart problems.
  • Lactic acidosis: A buildup of lactic acid in the blood due to impaired energy metabolism, leading to fatigue, nausea, and breathing difficulties.
  • Vision problems: Some individuals may experience optic atrophy, which leads to vision loss over time.

Diagnostic Procedures

Early diagnosis of MERRF is crucial for symptom management and supportive care. Diagnosis typically involves a combination of clinical evaluations, genetic testing, and specialized lab tests.

Clinical Evaluations and Neurological Exams

Doctors begin by reviewing a patient’s medical history and performing a neurological exam to assess reflexes, muscle strength, coordination, and seizure activity. They also check for sensory issues like numbness, hearing loss, or vision impairment.

Genetic Testing and Mitochondrial DNA Analysis

Since MERRF is caused by mitochondrial DNA mutations, genetic testing plays a key role in confirming a diagnosis. The m.8344A>G mutation in the MT-TK gene is the most common genetic change linked to MERRF. A blood or saliva sample is typically used for DNA analysis.

Muscle Biopsy and Other Diagnostic Tools

If genetic testing is inconclusive, a muscle biopsy may be performed. A small sample of muscle tissue is examined under a microscope to check for ragged red fibers, a key marker of MERRF.

Additional tests that may help confirm a diagnosis include:

  • Lactic acid and pyruvate levels: Elevated blood or cerebrospinal fluid levels indicate mitochondrial dysfunction.
  • Magnetic Resonance Imaging (MRI): Can reveal brain abnormalities associated with MERRF.
  • Electromyography (EMG): Assesses nerve and muscle function.

Differential Diagnosis

Since MERRF shares symptoms with other neurological disorders, an accurate diagnosis is essential. Conditions with similar presentations include:

Importance of Accurate Diagnosis

Since MERRF is a progressive condition, early and accurate diagnosis allows for better symptom management. A misdiagnosis could delay supportive therapies and lead to unnecessary treatments. Genetic testing, clinical assessments, and specialized laboratory tests ensure that MERRF is properly identified.

Treatment and Management

Since seizures and muscle spasms are common in MERRF, medications are often prescribed to help control these symptoms. These may include:

  • Antiepileptic drugs (AEDs): Medications like levetiracetam, valproic acid, or clonazepam can help manage seizures and myoclonus (muscle jerks). However, valproic acid should be used cautiously as it may worsen mitochondrial dysfunction.
  • Muscle relaxants: medications such as baclofen or benzodiazepines may help reduce muscle stiffness and spasms.
  • Cardiac medications: If heart problems arise, beta-blockers or pacemakers may be recommended to manage arrhythmias (irregular heartbeats).

While these treatments can help relieve symptoms, they do not address the underlying mitochondrial dysfunction.

Experimental Therapies and Research

Scientists are actively researching potential therapies for mitochondrial disorders like MERRF. Some promising areas of research include:

  • Gene therapy: Although still experimental, gene therapy aims to correct mitochondrial DNA mutations.
  • Mitochondrial-targeted antioxidants: Coenzyme Q10 (CoQ10), idebenone, and other antioxidants are being studied for their potential to improve mitochondrial function.
  • Exercise-based studies: Some research suggests that mild to moderate exercise may help improve muscle function in individuals with mitochondrial diseases.

While these treatments are not yet widely available, ongoing clinical trials may offer new hope for the future.

Supportive Therapies

Since MERRF can cause muscle weakness, coordination problems, and mobility challenges, physical and occupational therapy plays a key role in maintaining function.

  • Physical therapy (PT): Helps maintain muscle strength, improve mobility, and prevent joint stiffness.
  • Occupational therapy (OT): Focuses on adapting daily tasks to help individuals maintain independence. This may include using assistive devices like braces, walkers, or adaptive utensils.

Nutritional Support and Supplements

Since mitochondrial disorders affect energy production, proper nutrition is essential for individuals with MERRF. Some may have difficulty swallowing or metabolizing nutrients, so a high-energy diet may be recommended to help compensate for energy deficits. 

Healthcare providers may also suggest mitochondrial-supportive supplements, such as Coenzyme Q10 (CoQ10) and L-carnitine to aid energy production, riboflavin (Vitamin B2) to support mitochondrial function, and creatine as an alternative energy source for muscles. However, all supplements should be taken under medical supervision to avoid potential side effects.

Integrative Approaches

Small lifestyle adjustments can help manage fatigue and preserve energy. Using energy conservation techniques, such as pacing activities and taking breaks, can prevent exhaustion. 

Gentle exercise, like swimming or yoga, may help maintain mobility without straining muscles. Additionally, avoiding extreme temperatures is important, as both heat and cold can worsen muscle weakness. These strategies can improve daily function and overall well-being.

Mental Health Support and Counseling

Living with a progressive condition like MERRF can be emotionally challenging for both patients and caregivers. Mental health support is just as important as physical care.

  • Counseling and therapy: Speaking with a mental health professional can help individuals cope with stress, depression, or anxiety.
  • Support groups: Connecting with others who have MERRF can provide emotional support and practical advice.
  • Mindfulness and relaxation techniques: Practices like meditation, deep breathing, or guided imagery may help manage stress.

By combining medical treatments, supportive therapies, and holistic approaches, individuals with MERRF can improve their quality of life and better manage their symptoms. Ongoing research continues to offer hope for new treatments in the future.

Living with MERRF Syndrome

A MERRF diagnosis can be life-changing, but individuals and families can navigate the challenges more effectively with the right coping strategies, support systems, and community resources. Living with MERRF requires adaptability, resilience, and a strong network of support to maintain independence and well-being.

Daily Life and Coping Strategies

Since MERRF can cause muscle weakness, balance issues, and fatigue, everyday tasks may require adjustments. Some strategies that can help include:

  • Energy conservation techniques: breaking tasks into smaller steps and taking frequent rest breaks.
  • Assistive devices: Walkers, wheelchairs, and adaptive tools can make mobility and self-care easier.
  • Home modifications: Installing grab bars, ramps, and shower chairs can enhance safety and accessibility.
  • Establishing a routine: Predictability in daily schedules can help manage energy levels and reduce stress.

Emotional and Psychological Coping

Living with a progressive condition can take an emotional toll, leading to feelings of frustration, sadness, or isolation. Some ways to cope include:

  • Seeking professional support: Therapy or counseling can help process emotions and develop healthy coping strategies.
  • Practicing mindfulness and relaxation techniques: Meditation, deep breathing, or journaling can help reduce stress and improve mental clarity.
  • Setting realistic goals: Acknowledging limitations while celebrating small achievements can boost confidence.
  • Engaging in hobbies and interests: Finding enjoyable activities that align with physical abilities can bring joy and fulfillment.

Support Systems

Family members and caregivers are crucial in supporting individuals with MERRF, but caregiving can be physically and emotionally demanding. To provide the best care while maintaining their well-being, caregivers should learn about MERRF

Encourage independence whenever possible, and seek support groups for guidance and emotional relief. Practicing self-care, such as taking breaks and engaging in personal hobbies, is essential to prevent burnout.

Support Groups and Community Resources

Connecting with others who understand the challenges of MERRF can provide emotional comfort and practical advice. Support options include online forums, local support groups, and nonprofit organizations like the United Mitochondrial Disease Foundation (UMDF) and MitoAction, which offer educational resources, advocacy, and financial assistance programs. 

Hearing real-life experiences from individuals and families affected by MERRF can provide hope and perspective. Stories may highlight how patients manage daily challenges, how caregivers balance support and self-care, or the emotional journey of receiving a MERRF diagnosis.

Research and Future Directions

While there is no cure for MERRF syndrome, ongoing research continues to expand our understanding of the condition. Scientists and medical professionals are working to develop new therapies, improve symptom management, and explore potential cures.

Advances in genetics, drug development, and medical technology offer hope for better treatments in the future.

Current Research Trends

Since MERRF is caused by mutations in mitochondrial DNA (mtDNA), genetic research is a key focus in understanding and treating the disorder. Some important areas of study include:

  • Mitochondrial gene editing: Scientists are exploring techniques like CRISPR-based gene editing to correct mtDNA mutations.
  • Nuclear transfer techniques: research into mitochondrial replacement therapy (MRT) aims to stop mitochondrial disorders passed down through families by replacing embryos with healthy mtDNA.
  • Personalized medicine: Advances in genetic sequencing allow for more precise diagnosis and tailored treatment plans based on a patient’s unique genetic profile.

Novel Therapeutic Approaches

Researchers are developing new treatment options to improve mitochondrial function and slow disease progression. Promising approaches include mitochondrial-targeted antioxidants like Coenzyme Q10 and MitoQ, which may reduce oxidative stress and enhance energy production.

Exercise-based therapies are also being studied for their potential to improve muscle function, while stem cell research explores the possibility of regenerating damaged muscle and nerve tissue.

Future Prospects

Although there is no cure for MERRF yet, ongoing research is focused on gene therapy, which aims to repair faulty mitochondrial genes, and drug development, which seeks to enhance mitochondrial function. New developments in prenatal genetic screening could help find women who carry MERRF mutations, enabling early intervention and well-informed planning of reproduction.

The Role of Technology and Innovation

Emerging technologies are transforming the diagnosis and management of MERRF. AI-driven tools can analyze genetic data faster, while wearable health monitors help track muscle activity and heart function, allowing for more personalized treatment plans. 

Telemedicine is also expanding access to specialists and clinical trials, making expert care more accessible for those with rare disorders.

How to Get Involved

Patients and families can contribute to MERRF research by participating in clinical trials, consulting healthcare providers about experimental treatments, and joining patient registries to help scientists track disease progression. Even those not eligible for trials can support research through advocacy, fundraising, and awareness efforts. 

Organizations like the United Mitochondrial Disease Foundation (UMDF) rely on donations to fund critical research and provide patient support. Raising awareness and educating others can help drive public interest and funding, bringing hope for better treatments and a future cure.

[signup]

Key Takeaways

  • MERRF syndrome is a rare mitochondrial disorder inherited through maternal DNA, primarily affecting muscles and the nervous system, leading to progressive weakness, seizures, coordination issues, and ragged red fibers in muscle tissue.
  • Diagnosis relies on clinical evaluations, genetic testing for MT-TK mutations, and muscle biopsy, while distinguishing MERRF from similar conditions like MELAS and Lafora disease is crucial for appropriate care.
  • Treatment focuses on managing symptoms with antiepileptic drugs, muscle relaxants, and supportive therapies like physical therapy, nutritional supplements, and assistive devices, though no cure currently exists.
  • Ongoing research explores potential therapies, including mitochondrial-targeted antioxidants, exercise-based interventions, and experimental gene therapy aimed at correcting mitochondrial DNA mutations.
  • Patients and caregivers benefit from emotional support, energy conservation strategies, and community resources, while advocacy and participation in research initiatives help drive future treatment advancements.
The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!

Abdul-Fatah, A., Esmaeilisaraji, L., Juan, C. M., & Holcik, M. (2022). Mitochondrial disease registries worldwide: A scoping review. PLOS ONE, 17(10), e0276883. https://doi.org/10.1371/journal.pone.0276883

Bounds, C. G., & Nelson, V. L. (2024). Benzodiazepines. National Library of Medicine; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK470159/

Camp, K. M., Krotoski, D., Parisi, M. A., Gwinn, K., Cohen, B. M., Cox, C., Enns, G. M., Falk, M. J., Goldstein, A., Rashmi Gopal-Srivastava, Gorman, G. S., Hersh, S. P., Hirano, M., Freddie Ann Hoffman, Amel Karaa, MacLeod, E. L., McFarland, R., Mohan, C., Mulberg, A. E., & Odenkirchen, J. (2016). Nutritional interventions in primary mitochondrial disorders: Developing an evidence base. 119(3), 187–206. https://doi.org/10.1016/j.ymgme.2016.09.002

Chaitanya Amrutkar, & Riel-Romero, R. M. (2019, January 12). Juvenile Myoclonic Epilepsy. Nih.gov; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK537109/

Cleveland Clinic. (2021, May 10). Living with chronic illness. Cleveland Clinic. https://my.clevelandclinic.org/health/articles/4062-chronic-illness

Cleveland Clinic. (2023a, May 9). Mitochondrial Diseases. Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/15612-mitochondrial-diseases

Cleveland Clinic. (2023b, July 24). What Is MELAS Syndrome? Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/25149-melas-syndrome

Cloyd, J. (2023, March 7). An integrative medicine approach to fatigue. Rupa Health. https://www.rupahealth.com/post/an-integrative-medicine-approach-to-fatigue

Cohen, B. H. (2013). Neuromuscular and Systemic Presentations in Adults: diagnoses beyond MERRF and MELAS. Neurotherapeutics, 10(2), 227–242. https://doi.org/10.1007/s13311-013-0188-3

Craven, L., Tang, M.-X., Gorman, G. S., De Sutter, P., & Heindryckx, B. (2017). Novel reproductive technologies to prevent mitochondrial disease. Human Reproduction Update, 23(5), 501–519. https://doi.org/10.1093/humupd/dmx018

DeCesaris, L. (2023, March 23). Creatine: What you need to know. Rupa Health. https://www.rupahealth.com/post/creatine-what-you-need-to-know

DiMauro, S., & Michio Hirano. (2015, January 29). MERRF. Nih.gov; University of Washington, Seattle. https://www.ncbi.nlm.nih.gov/books/NBK1520/

Finsterer, J., Zarrouk-Mahjoub, S., & Shoffner, J. M. (2018). MERRF Classification: Implications for Diagnosis and Clinical Trials. Pediatric Neurology, 80, 8–23. https://doi.org/10.1016/j.pediatrneurol.2017.12.005

Fogleman, S., Santana, C., Bishop, C., Miller, A., & Capco, D. G. (2016). CRISPR/Cas9 and mitochondrial gene replacement therapy: promising techniques and ethical considerations. American Journal of Stem Cells, 5(2), 39. https://pmc.ncbi.nlm.nih.gov/articles/PMC5043096/

Gerow, S. (2024a, August 6). Preventing Hearing Loss: A Functional Medicine Approach to Protecting Your Hearing Health. Rupa Health. https://www.rupahealth.com/post/preventing-hearing-loss-functional-medicine-approach

Gerow, S. (2024b, October 23). If Your Patient is a Young Adult with Seizures, Run These Lab Tests. Rupa Health. https://www.rupahealth.com/post/if-your-patient-is-a-young-adult-with-seizures-run-these-lab-tests

Giaj Levra, A., & Amata, F. (2024). Myoclonic Epilepsy With Ragged Red Fiber Cardiomyopathy: A Case Report and Brief Review of Literature. Cureus, 16(8), e66745. https://doi.org/10.7759/cureus.66745

Hameed, S., & Tadi, P. (2020). Myoclonic Epilepsy and Ragged Red Fibers (MERF). PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK555923/

Henrique Carmona Alexandrino, Ferreira, M. A., Ramalho, D., Jesus, N. R., & Oliveira, M. J. (2023). Endocrine Challenges in Myoclonic Epilepsy With Ragged Red Fibers Syndrome: A Case Report. Cureus. https://doi.org/10.7759/cureus.51114

Huang, G., Wang, Y., & Yao, D. (2023). Myoclonic epilepsy with ragged red fibers syndrome associated with mitochondrial 3302A>G mutation in the MT‑TL1 gene: A case report. Experimental and Therapeutic Medicine, 25(2). https://doi.org/10.3892/etm.2023.11786

Hussain, S.-R. A., Yalvac, M. E., Khoo, B., Eckardt, S., & McLaughlin, K. J. (2021). Adapting CRISPR/Cas9 System for Targeting Mitochondrial Genome. Frontiers in Genetics, 12. https://doi.org/10.3389/fgene.2021.627050

Ibrahim, F., & Murr, N. (2021). Lafora Disease. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK482229/

Jeppesen, T. D. (2020). Aerobic Exercise Training in Patients With mtDNA-Related Mitochondrial Myopathy. Frontiers in Physiology, 11. https://doi.org/10.3389/fphys.2020.00349

Jiang, Q., Yin, J., Chen, J., Ma, X., Wu, M., Liu, G., Yao, K., Tan, B., & Yin, Y. (2020). Mitochondria-Targeted Antioxidants: A Step towards Disease Treatment. Oxidative Medicine and Cellular Longevity, 2020, e8837893. https://doi.org/10.1155/2020/8837893

Kawazoe, T., Tobisawa, S., Sugaya, K., Uruha, A., Miyamoto, K., Komori, T., Goto, Y., Nishino, I., Yoshihashi, H., Mizuguchi, T., Matsumoto, N., Egawa, N., Kawata, A., & Isozaki, E. (2022). Myoclonic Epilepsy with Ragged-red Fibers with Intranuclear Inclusions. Internal Medicine, 61(4), 547–552. https://doi.org/10.2169/internalmedicine.7767-21

Leigh syndrome | UMDF. (2020). Umdf.org. https://doi.org/10862113792/QEAICODpi6cDEIDourso

Levetiracetam (Oral Route) Description and Brand Names - Mayo Clinic. (n.d.). Www.mayoclinic.org. https://www.mayoclinic.org/drugs-supplements/levetiracetam-oral-route/description/drg-20068010

Lorenzoni, P. J., Scola, R. H., Kay, C. S. K., Silvado, C. E. S., & Werneck, L. C. (2014). When should MERRF (myoclonus epilepsy associated with ragged-red fibers) be the diagnosis? Arquivos de Neuro-Psiquiatria, 72(10), 803–811. https://doi.org/10.1590/0004-282x20140124

Mavraki, E., Labrum, R., Sergeant, K., Alston, C. L., Woodward, C., Smith, C., Knowles, C. V. Y., Patel, Y., Hodsdon, P., Baines, J. P., Blakely, E. L., Polke, J., Taylor, R. W., & Fratter, C. (2022). Genetic testing for mitochondrial disease: the United Kingdom best practice guidelines. European Journal of Human Genetics, 31(2), 148–163. https://doi.org/10.1038/s41431-022-01249-w

Mayo Clinic. (2022, August 22). Beta Blockers. Mayo Clinic; Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/high-blood-pressure/in-depth/beta-blockers/art-20044522

Mitochondrial Disease Support Groups | My Mito Mission. (2025, January 3). Mitochondrial Disease Charity | My Mito Mission. https://www.mymitomission.uk/supporting-you/peer-support-groups/

Moore, M., Yeske, P., & Parikh, S. (2023). Navigating Life With Primary Mitochondrial Myopathies: The Importance of the Patient Voice and Implications for Clinical Practice. Journal of Primary Care & Community Health, 14, 21501319231193875. https://doi.org/10.1177/21501319231193875

Myoclonic epilepsy with ragged-red fibers: MedlinePlus Genetics. (2014, May 1). Medlineplus.gov. https://medlineplus.gov/genetics/condition/myoclonic-epilepsy-with-ragged-red-fibers/

Noorda, G., van Achterberg, T., van der Hooft, T., Smeitink, J., Schoonhoven, L., & van Engelen, B. (2012). Problems of Adults with a Mitochondrial Disease – The Patients’ Perspective: Focus on Loss. JIMD Reports, 85–94. https://doi.org/10.1007/8904_2011_121

Nord. (2021). MERRF Syndrome. NORD (National Organization for Rare Disorders). https://rarediseases.org/rare-diseases/merrf-syndrome/

Pfeffer, G., Majamaa, K., Turnbull, D. M., Thorburn, D., & Chinnery, P. F. (2012). Treatment for mitochondrial disorders. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd004426.pub3

Preston, J. (2023, November 13). CoQ10 Testing: Why You Should Know Your Status On This Important Nutrient. Rupa Health. https://www.rupahealth.com/post/coq10-testing-why-you-should-know-your-status-on-this-important-nutrient

Rahman, M., & Nguyen, H. (2023). Valproic Acid (Divalproex Sodium). PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK559112/

Shirin Ghanavatian, & Armen Derian. (2019, October). Baclofen. Nih.gov; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK526037/

Sweetnich, J. (2023, April 28). Vitamin B2 (riboflavin) 101: RDA, testing, and supplementing. Rupa Health. https://www.rupahealth.com/post/vitamin-b2-riboflavin-101-rda-testing-and-supplementing

Thornton, B., Cohen, B., Copeland, W., & Maria, B. L. (2014). Mitochondrial Disease: Clinical Aspects, Molecular Mechanisms, Translational Science, and Clinical Frontiers. Journal of Child Neurology, 29(9), 1179–1207. https://doi.org/10.1177/0883073814537379

Tinker, R. J., Lim, A. Z., Stefanetti, R. J., & McFarland, R. (2021). Current and Emerging Clinical Treatment in Mitochondrial Disease. Molecular Diagnosis & Therapy, 25(2), 181–206. https://doi.org/10.1007/s40291-020-00510-6

Turnbull, H. E., Lax, N. Z., Diodato, D., Ansorge, O., & Turnbull, D. M. (2010). The mitochondrial brain: From mitochondrial genome to neurodegeneration. Biochimica et Biophysica Acta, 1802(1), 111–121. https://doi.org/10.1016/j.bbadis.2009.07.010

V. Duranovic, L. Lujic, J. Sekelj Fures, Rosko, S. P., M. Habek, Sertic, J., K. Vulin, & I. Dakovic. (2017). MERRF syndrome. European Journal of Paediatric Neurology, 21, e136–e136. https://doi.org/10.1016/j.ejpn.2017.04.1039

Wallace, D. C., & Chalkia, D. (2013). Mitochondrial DNA Genetics and the Heteroplasmy Conundrum in Evolution and Disease. Cold Spring Harbor Perspectives in Biology, 5(11), a021220–a021220. https://doi.org/10.1101/cshperspect.a021220

Wu, Y., Tay, H., Yang, J., Liao, H.-H., Ma, Y., & Wei, Y. (2023). Mitochondrial impairment and synaptic dysfunction are associated with neurological defects in iPSCs-derived cortical neurons of MERRF patients. Journal of Biomedical Science, 30(1). https://doi.org/10.1186/s12929-023-00966-8

Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Neurological
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.

Hey practitioners! 👋 Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.

Hey practitioners! 👋 Join Dr. Robert Silverman for an insightful webinar, "Food Sensitivities, GLP-1, and Gut Health" on April 2nd at 2 PM EST / 11 AM PST. In this session, you'll gain insight into how GLP-1 may play a role in gut function, metabolism, and immune response, how food sensitivities may be linked to digestive discomfort, and practical strategies to help support gut health and overall well-being. Register now to secure your spot!